Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 663

Results For "CE"

8147 News Found

Differentiation based on innovation is the way forward: S Aparna
News | April 26, 2022

Differentiation based on innovation is the way forward: S Aparna

Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'


Drugs Controller clears Covaxin, Corbevax and ZyCov-D for kids
News | April 26, 2022

Drugs Controller clears Covaxin, Corbevax and ZyCov-D for kids

The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)


USFDA approves first Covid-19 treatment for young children
Drug Approval | April 26, 2022

USFDA approves first Covid-19 treatment for young children

This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age


Lonza and Integral Molecular partner on biotherapeutics
News | April 26, 2022

Lonza and Integral Molecular partner on biotherapeutics

The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation


Roche and Fitterfly co-create 90-day diabetes programme
Startup | April 26, 2022

Roche and Fitterfly co-create 90-day diabetes programme

Designed to give instant insights on blood sugar, in-depth nutrition and wellness, this programme provides fitness assessments, personalisation and reports for doctors


SRL Diagnostics opens state-of-the-art laboratory in Jamshedpur
Diagnostic Center | April 26, 2022

SRL Diagnostics opens state-of-the-art laboratory in Jamshedpur

The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand


Sygnature Discovery acquires Peak Proteins
Biotech | April 26, 2022

Sygnature Discovery acquires Peak Proteins

Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes


Corbevax gets DCGI nod for Emergency Use in 5-12 years
Drug Approval | April 26, 2022

Corbevax gets DCGI nod for Emergency Use in 5-12 years

The approval comes soon after Corbevax was given the nod for 12-15-year group


DCGI grants Covaxin Emergency Use Approval for children 6-12 years
Drug Approval | April 26, 2022

DCGI grants Covaxin Emergency Use Approval for children 6-12 years

Covaxin was earlier approved for children 12-18 years of age


Bachem partners with Eli Lilly on oligonucleotide-based APIs
News | April 26, 2022

Bachem partners with Eli Lilly on oligonucleotide-based APIs

Under the terms of the agreement, Bachem will provide the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology